1. Volume 74, Issue 1, Pages 17-23 (July 2018)
The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score 
Kurt Miller, Joan Carles, Jürgen E. Gschwend, Hendrik Van Poppel, Joris Diels, Sabine D. Brookman-May 
European Urology 
Volume 74, Issue 1, Pages (July 2018)
DOI: /j.eururo
Copyright © 2017 European Association of Urology Terms and Conditions

2. Fig. 1
CONSORT study flow diagram. CONSORT=Consolidated Standards of Reporting Trials; ITT=intention to treat.
European Urology  , 17-23DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions

3. Fig. 2
Kaplan–Meier analysis of time-to-event end points with abiraterone acetate plus prednisone and prednisone: (A) overall survival; (B) radiographic progression-free survival. (C) time to chemotherapy; and (D) time to opiate use. AA=abiraterone acetate; P=prednisone.
European Urology  , 17-23DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions